stockrowAlvotech (ALVO) vs Amphastar Pharmaceuticals, Inc. (AMPH)
- Alvotech ALVO 4.58 −1.93%
- Amphastar Pharmaceuticals, Inc. AMPH 27.59 −1.53%
Alvotech and Amphastar Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Alvotech is the larger, with a market value of $1.8B against $1.2B — 1.5× the size. Alvotech has negative trailing earnings, so its P/E is not meaningful; Amphastar Pharmaceuticals, Inc. trades at 12.3×. Alvotech grew revenue faster over the last twelve months: 364.3% against 3.11%. Amphastar Pharmaceuticals, Inc. has the higher net margin (13.3% vs −101.1%) and the higher return on invested capital (6.12% vs 0.00%). Across the 17 metrics below, Amphastar Pharmaceuticals, Inc. leads on 14 and Alvotech on 3.
Valuation
Profitability
| Metric | ALVO | AMPH | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 42.71% | 46.81% | 53.51% |
| Operating margin | (42.43%) | 18.74% | 0.00% |
| Net margin | (101.05%) | 13.27% | (2.45%) |
| Free cash flow margin | 0.00% | 18.64% | 0.00% |
| Return on equity | 0.00% | 12.44% | (0.80%) |
| Return on assets | 0.00% | 5.86% | (1.67%) |
| Return on invested capital | 0.00% | 6.12% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack